- Anticoagulants and a routine extraction:
- Continue warfarin/DOACs for simple extractions with local hemostasis; DOAC reversal agents; INR-raising antibiotics; coordinate for higher-bleeding-risk surgery.
- ACE inhibitor angioedema in a dental patient:
- Bradykinin (not histamine) angioedema; airway-first management; stop the drug; lifelong ACE inhibitor avoidance after angioedema.
- Phenytoin, cyclosporine, and a calcium channel blocker:
- Classic gingival enlargement triad; plaque control + medication review (tacrolimus alternative); gingivectomy for residual fibrotic overgrowth.
- Chronic corticosteroids and the stress-dose question:
- HPA suppression; routine dentistry usually does NOT need stress dosing; stress-dose for severe stress only; adrenal crisis recognition.
- Bisphosphonates, denosumab, and MRONJ prevention:
- IV cancer-dose vs oral osteoporosis risk; complete bony procedures BEFORE therapy; atraumatic technique on therapy; denosumab RANKL vs bisphosphonate matrix.
- Chairside hypoglycemia from diabetes medications:
- Sulfonylurea + insulin hypoglycemia, oral glucose vs IM glucagon, SGLT2 euglycemic DKA peri-procedural caution, GLP-1 aspiration risk.
- Chemotherapy mucositis and cytopenia before dental work:
- 5-FU/methotrexate mucositis, ANC and platelet check before invasive work, supportive measures, defer elective work in cytopenic nadirs.
- SSRIs, bleeding tendency, and bruxism:
- Platelet serotonin depletion bleeding, SSRI/SNRI bruxism, avoid tramadol (serotonin syndrome), occlusal appliance plus physician coordination.
- The medication review as the high-yield intervention:
- Composite real-world polypharmacy patient: apixaban + metoprolol + amlodipine + metformin + empagliflozin + alendronate + omeprazole + sertraline, each changing the chairside plan.